Better Context Better Decisions

Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.

$599
Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, GLP-1RA + Basal, Glucose Monitoring, Insulin Delivery, Other, SGLT2i Jun 10 | 2019ADA 2019 Key Press Releases (June 9 and 10)Purchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, GLP-1RA + Basal, Insulin Delivery Jun 10 | 2019Novo ADA 2019 Investor Event HighlightsPurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery, Other Jun 10 | 2019Medtronic Calls Out Tandem and Dexcom; Medtronic ADA 2019 Investor EventPurchase Blast
$599
Posted in: Bolus Insulin, Dual/triple agonist, GLP-1RA, Glucose Monitoring, Insulin Delivery, SGLT2i Jun 08 | 2019Novo Oral Sema Data, Tirzepatide Ph2 Analyses, New Medtronic Pivotal Studies; ADA 2019 Key Press Releases (June 8)Purchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Glucose Monitoring, Insulin Delivery Jun 07 | 2019Tidepool Partners with Medtronic and Dexcom; ADA 2019 Key Press Releases (June 7)Purchase Blast
Free
Posted in: Basal Insulin, Bolus Insulin, Glucagon, Glucose Monitoring, Insulin Delivery, Other Jun 06 | 2019New Sanofi CEO; Xeris delayed: SENS approval, InPen-Dexcom; Zeal-BB; vTv; AdociaAccess Free Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Insulin Delivery, Other Jun 06 | 2019ADA ’19 Key Data and Partnership Press Releases (June 5)Purchase Blast
$599
Posted in: Basal Insulin Jun 05 | 2019New Bs-Glargine U100 Trial From LannettPurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery May 30 | 2019FENIX Analysis: Devices Promotional Materials Post-AACE 2019Purchase Blast
1 2 3 23

Get the Latest Analysis

Stay informed and aligned with frequent updates to keep a pulse on the industry.

If you already have an account, please Login. If you have any questions or would like to subscribe to our services, please contact Brady.